Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification by Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium Avium

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01355-09
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search